This article is 5 years old
DG: Anti-malaria drug may have reduced Covid-19 patients’ need for ICU
UPDATED 10.40PM | CORONAVIRUS | Malaysia’s use of an antimalarial drug appears to have prevented Covid-19 from worsening and thus contributed to fewer patients in the ICU.
Health Ministry director-general Dr Noor Hisham Abdullah said today that hospitals have been administering hydroxychloroquine on an off-label basis since the outbreak began...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable